VolitionRx Ltd. (VNRX) Starts Presentation at LD Micro Main Event
VolitionRx (NYSE: VNRX) is a multi-national life sciences company engaged in the development of simple, easy to use, cost effective blood tests designed to help diagnose a range of cancers. The tests are based on the technology platform of Nucleosomics®, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid – an indication that disease is present. As cancer screening programs become more widespread, Volition’s products aim to help to diagnose a range of cancers quickly, simply, accurately and cost effectively. Early diagnosis has the potential to not only prolong the life of patients,…







